Literature DB >> 16527603

Chromosomal aberrations and microsatellite instability of malignant peripheral nerve sheath tumors: a study of 10 tumors from nine patients.

Chikashi Kobayashi1, Yoshinao Oda, Tomonari Takahira, Teiyu Izumi, Kenichi Kawaguchi, Hidetaka Yamamoto, Sadafumi Tamiya, Tomomi Yamada, Shinya Oda, Kazuhiro Tanaka, Shuichi Matsuda, Yukihide Iwamoto, Masazumi Tsuneyoshi.   

Abstract

Malignant peripheral nerve sheath tumor (MPNST) is an uncommon soft tissue neoplasm with a poor prognosis, occurring sporadically or associated with neurofibromatosis type 1 (NF1); however, the histogenesis of MPNST remains unclear, especially in sporadic tumors. There are two major forms of genomic instability in human cancer: chromosomal instability (CIN) and microsatellite instability (MSI). An inverse relationship has recently been demonstrated between CIN and MSI in colorectal cancers. CIN and MSI are suggested to be individual pathways, which are involved in the pathogenesis and which may lead to specific clinical and pathological characteristics. To elucidate the chromosomal aberration as a consequence of CIN and MSI status of MPNST, we karyotyped 10 MPNSTs from nine patients, and examined the MSI of seven microsatellite markers using high-resolution fluorescence microsatellite analysis; 2 out of 10 cases (20%) had normal karyotypes, and 8 out of 10 cases (80%) revealed structural and numerical chromosomal aberrations. Three of the 10 cases (30%) showed near triploidy. The most frequent aberration was -22 (40%), followed by +2, +14, -13, -17, and -18 (30% each). An MSI-low status was observed in 30% of cases; the remaining cases showed microsatellite stability. These findings suggest that chromosomal aberration as a consequence of CIN has a greater role in the pathogenesis of MPNST than does that due to MSI.

Entities:  

Mesh:

Year:  2006        PMID: 16527603     DOI: 10.1016/j.cancergencyto.2005.07.006

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

Review 1.  Strong association between cancer and genomic instability.

Authors:  Christian Streffer
Journal:  Radiat Environ Biophys       Date:  2009-12-24       Impact factor: 1.925

2.  Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors.

Authors:  Douglas R Stewart; Alexander Pemov; Peter Van Loo; Eline Beert; Hilde Brems; Raf Sciot; Kathleen Claes; Evgenia Pak; Amalia Dutra; Chyi-Chia Richard Lee; Eric Legius
Journal:  Genes Chromosomes Cancer       Date:  2012-01-17       Impact factor: 5.006

3.  Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.

Authors:  Adrienne L Watson; Eric P Rahrmann; Branden S Moriarity; Kwangmin Choi; Caitlin B Conboy; Andrew D Greeley; Amanda L Halfond; Leah K Anderson; Brian R Wahl; Vincent W Keng; Anthony E Rizzardi; Colleen L Forster; Margaret H Collins; Aaron L Sarver; Margaret R Wallace; Stephen C Schmechel; Nancy Ratner; David A Largaespada
Journal:  Cancer Discov       Date:  2013-03-27       Impact factor: 39.397

4.  Low-grade malignant triton tumor of the neck: a case report and review of the literature.

Authors:  Taissir Omar; Hanaa Raslan; Sahar El Sheikh; Moataz Rizq; Awatef Draz
Journal:  Case Rep Pathol       Date:  2014-09-22

5.  Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma.

Authors:  Takamichi Ito; Kenichi Kohashi; Yuichi Yamada; Takeshi Iwasaki; Akira Maekawa; Masaaki Kuda; Daichi Hoshina; Riichiro Abe; Masutaka Furue; Yoshinao Oda
Journal:  J Cancer       Date:  2016-04-27       Impact factor: 4.207

6.  Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.

Authors:  Suguru Fukushima; Makoto Endo; Yoshihiro Matsumoto; Jun-Ichi Fukushi; Tomoya Matsunobu; Ken-Ichi Kawaguchi; Nokitaka Setsu; Keiichiro IIda; Nobuhiko Yokoyama; Makoto Nakagawa; Kenichiro Yahiro; Yoshinao Oda; Yukihide Iwamoto; Yasuharu Nakashima
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

7.  Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors.

Authors:  Andrew Feber; Gareth A Wilson; Lu Zhang; Nadege Presneau; Bernadine Idowu; Thomas A Down; Vardhman K Rakyan; Luke A Noon; Alison C Lloyd; Elia Stupka; Vassia Schiza; Andrew E Teschendorff; Gary P Schroth; Adrienne Flanagan; Stephan Beck
Journal:  Genome Res       Date:  2011-02-01       Impact factor: 9.043

8.  WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth.

Authors:  Craig S Thomson; Jay Pundavela; Melissa R Perrino; Robert A Coover; Kwangmin Choi; Katherine E Chaney; Tilat A Rizvi; David A Largaespada; Nancy Ratner
Journal:  Oncogene       Date:  2021-06-02       Impact factor: 9.867

9.  Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.

Authors:  Jacqueline D Peacock; David Cherba; Kevin Kampfschulte; Mallory K Smith; Noel R Monks; Craig P Webb; Matthew Steensma
Journal:  J Transl Med       Date:  2013-09-17       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.